Newsverz
Health ·
Swedish Study Links Semaglutide to Lower Hospitalization Risk in Bipolar Disorder
A large Swedish nationwide cohort study of people with bipolar disorder found that those using the drug semaglutide had a 21 percent lower risk of psychiatric hospitalization and a 17 percent lower risk of bipolar relapse, an association not seen with other GLP-1 receptor agonist drugs.